{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:38Z","timestamp":1788307778799,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09969-8","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:11:09Z","timestamp":1728562269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors of moderate-to-severe side-effects following COVID-19 mRNA booster vaccination: a prospective cohort study among primary health care providers in Belgium"],"prefix":"10.1186","volume":"24","author":[{"given":"Julie","family":"Domen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Digregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Van Ngoc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els","family":"Duysburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Scholtes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"9969_CR1","unstructured":"Agency EM. EMA recommends first COVID-19 vaccine for authorisation in the EU [Internet]. 2020 [cited 2022 Mar 10]. Available from: https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-first-covid-19-vaccine-authorisation-eu"},{"key":"9969_CR2","unstructured":"Agency EM. Spikevax (previously COVID-19 Vaccine Moderna) [Internet]. 2021 [cited 2022 Mar 10]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spikevax"},{"key":"9969_CR3","doi-asserted-by":"crossref","unstructured":"Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021 Feb 4;384(5):403\u201316.","DOI":"10.1056\/NEJMoa2035389"},{"key":"9969_CR4","doi-asserted-by":"crossref","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603\u201315.","DOI":"10.1056\/NEJMoa2034577"},{"key":"9969_CR5","doi-asserted-by":"crossref","unstructured":"Moreira ED, Kitchin N, Xu X, Dychter SS, Lockhart S, Gurtman A, et al. Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine. N Engl J Med. 2022 May 19;386(20):1910\u201321.","DOI":"10.1056\/NEJMoa2200674"},{"key":"9969_CR6","doi-asserted-by":"crossref","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022 Mar 1;399(10328):924\u201344.","DOI":"10.1016\/S0140-6736(22)00152-0"},{"key":"9969_CR7","doi-asserted-by":"crossref","unstructured":"Adriaenssens N, Scholtes B, Bruyndonckx R, Van Ngoc P, Verbakel JYJ, De Sutter A, et al. Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up. BMJ Open. 2022\/09\/20 ed. 2022 Sep 19;12(9):e065897.","DOI":"10.1136\/bmjopen-2022-065897"},{"key":"9969_CR8","doi-asserted-by":"crossref","unstructured":"Adriaenssens N, Scholtes B, Bruyndonckx R, Verbakel JY, De Sutter A, Heytens S, et al. Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol. BMJ Open. 2022 Jan;12(1):e054688.","DOI":"10.1136\/bmjopen-2021-054688"},{"key":"9969_CR9","doi-asserted-by":"crossref","unstructured":"Ferdinands JM, Rao S, Dixon BE, Mitchell PK, DeSilva MB, Irving SA, et al. Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study. Bmj. 2022;379.","DOI":"10.1136\/bmj-2022-072141"},{"key":"9969_CR10","doi-asserted-by":"crossref","unstructured":"Loubet P, Laureillard D, Martin A, Larcher R, Sotto A. Why promoting a COVID-19 vaccine booster dose? Anaesth Crit Care Pain Med. 2021\/12\/21 ed. 2021 Dec;40(6):100967.","DOI":"10.1016\/j.accpm.2021.100967"},{"key":"9969_CR11","doi-asserted-by":"crossref","unstructured":"Larson HJ, Gakidou E, Murray CJL. The Vaccine-Hesitant Moment. N Engl J Med. 2022 Jul 7;387(1):58\u201365.","DOI":"10.1056\/NEJMra2106441"},{"key":"9969_CR12","unstructured":"Booster vaccination against COVID-19 for the general population. Superior Health Council.; 2021."},{"key":"9969_CR13","unstructured":"COVID-19 vaccination: Autumn\/Winter season 2022\u20132023. Superior Health Council.; 2022."},{"key":"9969_CR14","doi-asserted-by":"crossref","unstructured":"Vermeiren E, Van Loenhout JAF, Nasiadka L, Stouten V, Billuart M, Van Evercooren I, et al. Factors underlying COVID-19 booster vaccine uptake among adults in Belgium. BMC Res Notes. 2023 Nov 11;16(1):328.","DOI":"10.1186\/s13104-023-06608-4"},{"key":"9969_CR15","doi-asserted-by":"crossref","unstructured":"Dziedzic A, Issa J, Hussain S, Tanasiewicz M, Wojtyczka R, Kubina R, et al. COVID-19 vaccine booster hesitancy (VBH) of healthcare professionals and students in Poland: Cross-sectional survey-based study. Front Public Health. 2022 Jul 25;10:938067.","DOI":"10.3389\/fpubh.2022.938067"},{"key":"9969_CR16","doi-asserted-by":"crossref","unstructured":"\u0130ki\u0131\u015f\u0131k H, Sezerol MA, Ta\u015f\u00e7\u0131 Y, Maral I. COVID-19 vaccine hesitancy and related factors among primary healthcare workers in a district of Istanbul: a cross-sectional study from Turkey. Fam Med Community Health. 2022 Apr 1;10(2):e001430.","DOI":"10.1136\/fmch-2021-001430"},{"key":"9969_CR17","doi-asserted-by":"crossref","unstructured":"Digregorio M, Van Ngoc P, Domen J, Bognar Z, Duysburgh E, Hendrickx G, et al. Primary Healthcare Providers\u2019 Views on Periodic COVID-19 Booster Vaccination for Themselves and Their Patients: A 2023 Nationwide Survey in Belgium. Vaccines. 2024 Jul 3;12(7):740.","DOI":"10.3390\/vaccines12070740"},{"key":"9969_CR18","doi-asserted-by":"crossref","unstructured":"Ratzan S, Schneider EC, Hatch H, Cacchione J. Missing the Point \u2014 How Primary Care Can Overcome Covid-19 Vaccine \u201cHesitancy.\u201d N Engl J Med. 2021 Jun 24;384(25):e100.","DOI":"10.1056\/NEJMp2106137"},{"key":"9969_CR19","doi-asserted-by":"crossref","unstructured":"Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021 May;194:245\u201351.","DOI":"10.1016\/j.puhe.2021.02.025"},{"key":"9969_CR20","doi-asserted-by":"crossref","unstructured":"Chalkias S, Eder F, Essink B, Khetan S, Nestorova B, Feng J, et al. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2\/3 trial. Nat Med. 2022 Nov 1;28(11):2388\u201397.","DOI":"10.1038\/s41591-022-02031-7"},{"key":"9969_CR21","doi-asserted-by":"crossref","unstructured":"Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Poverty. 2021 Dec 1;10(1):132.","DOI":"10.1186\/s40249-021-00915-3"},{"key":"9969_CR22","doi-asserted-by":"crossref","unstructured":"Chen M, Yuan Y, Zhou Y, Deng Z, Zhao J, Feng F, et al. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials. Infect Poverty. 2021 Dec 1;10(1):94.","DOI":"10.1186\/s40249-021-00878-5"},{"key":"9969_CR23","doi-asserted-by":"crossref","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. Lancet Infect Dis. 2021 Jul 1;21(7):939\u201349.","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"9969_CR24","doi-asserted-by":"crossref","unstructured":"Rosenblum HG, Gee J, Liu R, Marquez PL, Zhang B, Strid P, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis. 2022 Jun 1;22(6):802\u201312.","DOI":"10.1016\/S1473-3099(22)00054-8"},{"key":"9969_CR25","doi-asserted-by":"crossref","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons K. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med. 2015 Jan 1;13(1):1.","DOI":"10.1186\/s12916-014-0241-z"},{"key":"9969_CR26","unstructured":"Stef VB. Flexible Imputation of Missing Data. [Internet]. 2018. Available from: https:\/\/stefvanbuuren.name\/fimd\/"},{"key":"9969_CR27","doi-asserted-by":"crossref","unstructured":"Barnard JRDB. Small-Sample Degrees of Freedom with Multiple Imputation. Biometrika. 1999;86(4):948\u2009\u2212\u200955.","DOI":"10.1093\/biomet\/86.4.948"},{"key":"9969_CR28","doi-asserted-by":"crossref","unstructured":"Salazar A, Ojeda B, Due\u00f1as M, Fern\u00e1ndez F, Failde I. Simple generalized estimating equations (GEEs) and weighted generalized estimating equations (WGEEs) in longitudinal studies with dropouts: guidelines and implementation in R. Stat Med. 2016 Aug 30;35(19):3424\u201348.","DOI":"10.1002\/sim.6947"},{"key":"9969_CR29","unstructured":"Harell FE. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis [Internet]. Cham: Springer International Publishing; 2015 [cited 2024 Jun 10]. (Springer Series in Statistics). Available from: https:\/\/link.springer.com\/10.1007\/978-3-319-19425-7"},{"key":"9969_CR30","doi-asserted-by":"crossref","unstructured":"Bendel RB, Afifi AA. Comparison of Stopping Rules in Forward \u201cStepwise\u201d Regression. J Am Stat Assoc. 1977 Mar;72(357):46.","DOI":"10.2307\/2286904"},{"key":"9969_CR31","doi-asserted-by":"crossref","unstructured":"Wei P. Akaike\u2019s Information Criterion in Generalized Estimating Equations. Biometrics. 2001;57:120\u20135.","DOI":"10.1111\/j.0006-341X.2001.00120.x"},{"key":"9969_CR32","doi-asserted-by":"crossref","unstructured":"Panken AM, Heymans MW. A simple pooling method for variable selection in multiply imputed datasets outperformed complex methods. BMC Med Res Methodol. 2022 Dec;22(1):214.","DOI":"10.1186\/s12874-022-01693-8"},{"key":"9969_CR33","unstructured":"Sciensano the B institute for health. Administered vaccines by date, region, age, sex, brand and dose [Internet]. [cited 2023 Jan 1]. Available from: https:\/\/epistat.sciensano.be\/covid\/"},{"key":"9969_CR34","doi-asserted-by":"crossref","unstructured":"Ali MD, Almadan LZ, Alghamdi RA, Alghamdi AS, Almarhoon SA, Hassan YA, et al. Evaluation of Prevalence of Side-Effects Associated with Booster Dose of mRNA-Based COVID-19 Vaccine Among Healthcare Workers in Eastern Province, Saudi Arabia: A Descriptive Cross-Sectional Study. Infect Drug Resist. 2022 Aug 1;15:4335\u201346.","DOI":"10.2147\/IDR.S374265"},{"key":"9969_CR35","doi-asserted-by":"crossref","unstructured":"Galanis P, Katsiroumpa A, Vraka I, Chrysagi V, Siskou O, Konstantakopoulou O, et al. Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece. Vacunas. 2023;24(3):210\u20137.","DOI":"10.1016\/j.vacun.2023.05.005"},{"key":"9969_CR36","doi-asserted-by":"crossref","unstructured":"Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, et al. Analysis of COVID-19 Vaccine Type and Adverse Effects Following Vaccination. JAMA Netw Open. 2021 Dec 22;4(12):e2140364.","DOI":"10.1001\/jamanetworkopen.2021.40364"},{"key":"9969_CR37","doi-asserted-by":"crossref","unstructured":"Chen PY, Wu BJ, Su MC, Lin YH, Chiang SC, Wu JC, et al. Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose. Vaccines. 2022 Jul 13;10(7):1115.","DOI":"10.3390\/vaccines10071115"},{"key":"9969_CR38","doi-asserted-by":"crossref","unstructured":"Klugar M, Riad A, Mekhemar M, Conrad J, Buchbender M, Howaldt HP, et al. Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology. 2021 Aug 5;10(8):752.","DOI":"10.3390\/biology10080752"},{"key":"9969_CR39","doi-asserted-by":"crossref","unstructured":"Hin LY, Wang YG. Working-correlation-structure identification in generalized estimating equations. Stat Med. 2008\/12\/10 ed. 2009 Feb 15;28(4):642\u201358.","DOI":"10.1002\/sim.3489"},{"key":"9969_CR40","unstructured":"Interim statement on the use of additional booster doses of emergency use listed mRNA vaccines against COVID-19. [Internet]. World Health Oranization; 2022 May. Available from: https:\/\/www.who.int\/news\/item\/17-05-2022-interim-statement-on-the-use-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19"},{"key":"9969_CR41","unstructured":"Vaccine Safety Datalink (VSD): [Internet]. Centers for Disease Control and Prevention; 2023. Available from: https:\/\/www.cdc.gov\/vaccinesafety\/ensuringsafety\/monitoring\/vsd\/index.html"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09969-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09969-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T12:13:26Z","timestamp":1728562406000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09969-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9969"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09969-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"14 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical Approval has been granted by the Ethics Committee of the University Hospital of Antwerp\/University of Antwerp (Belgian registration number: 3002020000237). Informed consent was obtained from all individual participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1135"}}